BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16837897)

  • 1. The role of CD44 adhesion molecule in oral cavity cancer.
    Georgolios A; Batistatou A; Charalabopoulos A; Manolopoulos L; Charalabopoulos K
    Exp Oncol; 2006 Jun; 28(2):94-8. PubMed ID: 16837897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma.
    Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A
    Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for oral premalignancy and cancer: what platform and which biomarkers?
    Lingen MW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecule CD44 expression in non-tumor epithelium adjacent to laryngeal cancer.
    González-Moles MA; Esteban F; Bravo-Pérez JJ; Bravo-Perez M; Ruiz-Avila I; Gil-Montoya JA; González-Moles S
    Onkologie; 2006 Feb; 29(1-2):9-13. PubMed ID: 16514248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 family and gynaecological cancer.
    Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
    In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma.
    Lyons AJ; Jones J
    Int J Oral Maxillofac Surg; 2007 Aug; 36(8):671-9. PubMed ID: 17643963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining.
    Lo WY; Lai CC; Hua CH; Tsai MH; Huang SY; Tsai CH; Tsai FJ
    J Proteome Res; 2007 Jun; 6(6):2143-51. PubMed ID: 17451265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral squamous cell carcinoma: new insights.
    Jordan RC; Daley T
    J Can Dent Assoc; 1997; 63(7):517-8, 521-5. PubMed ID: 9264211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431.
    Atsumi N; Ishii G; Kojima M; Sanada M; Fujii S; Ochiai A
    Biochem Biophys Res Commun; 2008 Aug; 373(1):36-41. PubMed ID: 18539139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
    Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the soft tissues of the oral cavity.
    Orlian AI
    N Y State Dent J; 1983 Nov; 49(9):704, 706, 709. PubMed ID: 6358977
    [No Abstract]   [Full Text] [Related]  

  • 19. Restricted-expressed proliferation-associated protein (Repp86) expression in squamous cell carcinoma of the oral cavity.
    Fenner M; Wehrhan F; Jehle M; Amann K; Radespiel-Tröger M; Grabenbauer G; Zenk J; Nkenke E; Schinhammer M; Schultze-Mosgau S
    Strahlenther Onkol; 2005 Dec; 181(12):755-61. PubMed ID: 16362784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.